Karyopharm Therapeutics (KPTI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BLDR braces for Q2 earnings hit as housing softness and margin pressure weigh. Can innovation offset the slump?

Citigroup, the global investment banking and financial services giant, recently hiked its price target for the Coinbase ...